Highlights Tissue microarrays and germline DNA from women recruited to the phase 3 trial. ICON7. underwent quantitative immunofluorescence for c-MET/VEGFR-2 co-expression and genetic sequencing for single nucleotide polymorphisms (SNPs) VEGF-pathway genes. High c-MET/VEGFR-2 co-localisation on tumour tissue independently predicted worse survival in bevacizumab-treated epithelial ovari... https://www.lightemupsequences.com/